LearnGlossaryMarketStocksSuperinvestorsSign in

MASI

Masimo Corporation

Healthcare · $9.4B market cap

Verdict

We can't put a fair value on MASI right now. Our value came out at less than a tenth of the share price. When our answer is that far from the market, the method most likely doesn't fit this company, so we don't publish a number.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth11.4% a year✓
Equity per share growth14.1% a year✓
Sales growth11.8% a year✓
Free cash flow growth9.7% a year✗
Return on invested capital3.3%✗

Follow MASI

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds MASI right now. In Q1 2026, 2 sold out. Who we track

Moves in Q1 2026

Sold out: Viking Global Investors, First Eagle Investment Management

About Masimo Corporation

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Jun 12, 2026. How the Payback Price works